- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: γδ T Cell, non small lung cancer, Without EGFR Mutation
Total 498797 results
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedNon-Small-Cell Lung CarcinomaUnited States, China, Taiwan, Spain, Korea, Republic of, France, Canada, Hong Kong, Japan, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Beta Pharma ShanghaiActive, not recruiting
-
Yuhan CorporationCompleted
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
Fudan UniversityCompleted
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)TerminatedRecurrent Squamous Cell Lung Carcinoma | Recurrent Lung Adenocarcinoma | Stage IV Lung Adenocarcinoma | Recurrent Large Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma | Stage IV Large Cell Lung CarcinomaUnited States, Mexico
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
First Affiliated Hospital of Zhejiang UniversityEnrolling by invitationNon Small Cell Lung CancerChina
-
National Cancer Institute, NaplesActive, not recruitingNon-squamous Non-small Cell Lung CancerItaly
-
First Affiliated Hospital of Zhejiang UniversityAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharmaCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
Alpha Biopharma (Jiangsu) Co., Ltd.CompletedNon-small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationChina, Korea, Republic of, Singapore, Taiwan
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Millennium Pharmaceuticals, Inc.Approved for marketing
-
Thomas Jefferson UniversityCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Health Care Provider | Activating ALK Gene Mutation Negative | Activating EGFR Gene Mutation Negative | Activating ROS1 Gene Mutation NegativeUnited States
-
ETOP IBCSG Partners FoundationSpanish Lung Cancer GroupCompletedLung CancerSpain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
-
Checkpoint Therapeutics, Inc.CompletedLung Diseases | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, Thailand, New Zealand, Australia, Poland
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
National Cancer Centre, SingaporeTerminatedNon-small Cell Lung Cancer | Leptomeningeal Disease | Central Nervous System MetastasesSingapore
-
Spanish Lung Cancer GroupCompletedNon-Small Cell Lung CancerSpain, France, Italy
-
Fundación GECPCompletedNon Small Cell Lung CancerSpain
-
Beta Pharma ShanghaiCompleted
-
Beta Pharma ShanghaiCompletedNon-small Cell Lung CancerChina
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedNon-Small Cell Lung CarcinomaUnited States
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
AstraZenecaTerminated
-
Sihuan Pharmaceutical Holdings Group Ltd.Covance; XuanZhu Pharma Co., Ltd.CompletedAdvanced Solid TumorsUnited States
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-small Cell Lung CancerChina
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
Exosome Diagnostics, Inc.Active, not recruitingCarcinoma, Non-Small-Cell LungUnited States
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Yuhan CorporationActive, not recruitingEGFR Gene MutationKorea, Republic of
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Korea University Guro HospitalChong Kun Dang Pharmaceutical Corp.Active, not recruitingEGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan